Development of novel biotinylated chitosan-decorated docetaxel-loaded nanocochleates for breast cancer targeting

References

• Nabholtz J-MA, Reese DM, Lindsay M-A, et al. Docetaxel in the treatment of breast cancer: an update on recent studies. Semin Oncol. 2002;29:28–34.
   PubMed Web of Science ®Google Scholar
• Lee SW, Yun MH, Jeong SW, et al. Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system. J Control Release. 2011;155:262–271.
   PubMed Web of Science ®Google Scholar
• Wang DK, Zhang CX, Zhang WT, et al. Characteristics and pharmacokinetics of docetaxel liposome containing Tween 80 or PEG-DSPE. J Drug Deliv Sci Technol. 2008;18:253–257.
   Web of Science ®Google Scholar
• Ma J, Zhuang H, Zhuang Z, et al. Development of docetaxel liposome surface modified with CD133 aptamers for lung cancer targeting. Artif Cells Nanomedicine Biotechnol. 2017 [Oct 30]; [8 p.]. DOI:10.1080/21691401.2017.1394874
   Web of Science ®Google Scholar
• Esmaeili F, Dinarvand R, Ghahremani MH, et al. Docetaxel-albumin conjugates: preparation, in vitro evaluation and biodistribution studies. J Pharm Sci. 2009;98:2718–2730.
   PubMed Web of Science ®Google Scholar
• Zeng X, Tao W, Mei L, et al. Docetaxel-loaded nanoparticles of dendrimer-like amphiphilic copolymer for cancer therapy. J Control Release. 2015;213:e119.
   PubMed Web of Science ®Google Scholar
• Ahmad N, Alam MA, Ahmad R, et al. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer. Artif Cells Nanomedicine Biotechnol. 2018;46:432–446.
   PubMed Web of Science ®Google Scholar
• Mi Y, Zhao J, Feng SS. Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer. J. Control. Release. 2013;169:185–192.
   PubMed Web of Science ®Google Scholar
• Tong SW, Xiang B, Dong DW, et al. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles. Int J Pharm. 2012;434:413–419.
   PubMed Web of Science ®Google Scholar
• Valicherla GR, Dave KM, Syed AA, et al. Formulation optimization of docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity. Sci Rep. 2016;6:26895.
   PubMed Web of Science ®Google Scholar
• Thotakura N, Sharma G, Singh B, et al. Aspartic acid derivatized hydroxylated fullerenes as drug delivery vehicles for docetaxel: an explorative study. Artif Cells Nanomedicine Biotechnol. 2017 [Oct 25]; [10 p.]. DOI:10.1080/21691401.2017.1392314
   PubMed Web of Science ®Google Scholar
• Park MH, Keum CG, Song JY, et al. A novel aqueous parenteral formulation of docetaxel using prodrugs. Int J Pharm. 2014;462:1–7.
   PubMed Web of Science ®Google Scholar
• Rezaei M, Abbasi A, Varshochian R, et al. NanoMIL-100(Fe) containing docetaxel for breast cancer therapy. Artif Cells Nanomedicine Biotechnol. 2017 [Aug 24]; [12 p.]. DOI:10.1080/21691401.2017.1369425
   PubMed Web of Science ®Google Scholar
• Engels FK, Mathot RAA, Verweij J. Alternative drug formulations of docetaxel: a review. Anticancer Drugs. 2007;18:95–103.
   PubMed Web of Science ®Google Scholar
• Pawar A, Bothiraja C, Shaikh K, et al. An insight into cochleates, a potential drug delivery system. RSC Adv. 2015;5:81188–81202.
   Web of Science ®Google Scholar
• Liu M, Zhong X, Yang Z. Chitosan functionalized nanocochleates for enhanced oral absorption of cyclosporine A. Sci Rep. 2017;7:41322.
   PubMed Web of Science ®Google Scholar
• Asprea M, Leto I, Bergonzi MC, et al. Thyme essential oil loaded in nanocochleates: encapsulation efficiency, in vitro release study and antioxidant activity. LWT - Food Sci Technol. 2017;77:497–502.
   Web of Science ®Google Scholar
• Soininen SK, Lehtolainen-Dalkilic P, Karppinen T, et al. Targeted delivery via avidin fusion protein: intracellular fate of biotinylated doxorubicin derivative and cellular uptake kinetics and biodistribution of biotinylated liposomes. Eur J Pharm Sci. 2012;47:848–856.
   PubMed Web of Science ®Google Scholar
• Yang W, Cheng Y, Xu T, et al. Targeting cancer cells with biotin-dendrimer conjugates. Eur J Med Chem. 2009;44:862–868.
   PubMed Web of Science ®Google Scholar
• Pulkkinen M, Pikkarainen J, Wirth T, et al. Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin-biotin technology: formulation development and in vitro anticancer activity. Eur J Pharm Biopharm. 2008;70:66–74.
   PubMed Web of Science ®Google Scholar
• Chen H, Nan W, Wei X, et al. Toxicity, pharmacokinetics, and in vivo efficacy of biotinylated chitosan surface-modified PLGA nanoparticles for tumor therapy. Artif Cells Nanomedicine Biotechnol. 2017;45:1115–1122.
   PubMed Web of Science ®Google Scholar
• Zempleni J, Wijeratne SSK, Hassan YI. Biotin. Biofactors. 2009;35:36–46.
   PubMed Web of Science ®Google Scholar
• Vadlapudi AD, Vadlapatla RK, Mitra AK. Sodium dependent multivitamin transporter (SMVT): a potential target for drug delivery. Curr. Drug Targets. 2012;13:994–1003.
   PubMed Web of Science ®Google Scholar
• Yuan Q, Venkatasubramanian R, Hein S, et al. A stimulus-responsive magnetic nanoparticle drug carrier: magnetite encapsulated by chitosan-grafted-copolymer. Acta Biomater. 2008;4:1024–1037.
   PubMed Web of Science ®Google Scholar
• Ahmadi Nasab N, Hassani Kumleh H, Beygzadeh M, et al. Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment. Artif Cells Nanomed Biotechnol. 2018;46:75–81.
   PubMed Web of Science ®Google Scholar
• Wang F, Wang Y, Ma Q, et al. Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics. Artif Cells Nanomedicine Biotechnol. 2017;45:1530–1538.
   PubMed Web of Science ®Google Scholar
• Pandit J, Sultana Y, Aqil M. Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation. Artif Cells Nanomedicine Biotechnol. 2017;45:1397–1407.
   PubMed Web of Science ®Google Scholar
• Balan V, Redinciuc V, Tudorachi N, et al. Biotinylated N-palmitoyl chitosan for design of drug loaded self-assembled nanocarriers. Eur Polym J. 2016;81:284–294.
   Web of Science ®Google Scholar
• Pons M, Foradada M, Estelrich J. Liposomes obtained by the ethanol injection method. Int J Pharm. 1993;95:51–56.
   Web of Science ®Google Scholar
• Zarif L. Drug delivery by lipid cochleates. Meth Enzymol. 2005;391:314–329.
   PubMed Web of Science ®Google Scholar
• Pawar AP, Vinugala D, Bothiraja C. Nanocochleates derived from nanoliposomes for paclitaxel oral use: preparation, characterization, in vitro anticancer testing, bioavailability and biodistribution study in rats. Biomed Pharmacother. 2014 [Nov 20]; [9 p.]. DOI:10.1016/j.biopha.2014.11.014
   Google Scholar
• Chu C, Xu P, Zhao H, et al. Effect of surface ligand density on cytotoxicity and pharmacokinetic profile of docetaxel loaded liposomes. Asian J Pharm Sci. 2016;11:655–661.
   Web of Science ®Google Scholar
• Pawar A, Singh S, Rajalakshmi S, et al. Development of fisetin-loaded folate functionalized pluronic micelles for breast cancer targeting. Artif Cells Nanomedicine Biotechnol. 2018 [Jan 15]; [15 p.]. DOI:10.1080/21691401.2018.1423991
   Web of Science ®Google Scholar
• Chen H, Xie LQ, Qin J, et al. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin. Colloids Surf B Biointerfaces. 2016;138:1–9.
   PubMed Web of Science ®Google Scholar
• Pavia DL, Lampman GM, Kriz GS. Introduction to Spectroscopy third edition. Thomson Learn Inc 2001;15:579.
   Google Scholar
• Sugimoto M, Morimoto M, Sashiwa H, et al. Preparation and characterization of water-soluble chitin and chitosan derivatives. Carbohydr Polym. 1998;36:49–59.
   Web of Science ®Google Scholar
• Umeyama M, Kira A, Nishimura K, et al. Interactions of bovine lactoferricin with acidic phospholipid bilayers and its antimicrobial activity as studied by solid-state NMR. Biochim Biophys Acta - Biomembr. 2006;1758:1523–1528.
   PubMed Web of Science ®Google Scholar
• Li J, Wang X, Zhang T, et al. A review on phospholipids and their main applications in drug delivery systems. Asian J Pharm Sci. 2014;10:81–98.
   Web of Science ®Google Scholar
• Du W, Hong L, Yao T, et al. Synthesis and evaluation of water-soluble docetaxel prodrugs-docetaxel esters of malic acid. Bioorganic Med Chem. 2007;15:6323–6330.
   PubMed Web of Science ®Google Scholar
• Wang L, Liu Z, Liu D, et al. Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity. Int J Pharm. 2011;413:194–201.
   PubMed Web of Science ®Google Scholar
• Pedersen UR, Leidy C, Westh P, et al. The effect of calcium on the properties of charged phospholipid bilayers. Biochim Biophys Acta - Biomembr. 2006;1758:573–582.
   PubMed Web of Science ®Google Scholar
• Pawar A, Patel R, Arulmozhi S, et al. d-[small alpha]-Tocopheryl polyethylene glycol 1000 succinate conjugated folic acid nanomicelles: towards enhanced bioavailability, stability, safety, prolonged drug release and synergized anticancer effect of plumbagin. RSC Adv. 2016;6:78106–78121.
   Web of Science ®Google Scholar
• Bothiraja C, Kapare HS, Pawar AP, et al. Development of plumbagin-loaded phospholipid-Tween(R) 80 mixed micelles: formulation, optimization, effect on breast cancer cells and human blood/serum compatibility testing. Ther Deliv. 2013;4:1247–1259.
   PubMedGoogle Scholar
• Bothiraja C, Yojana BD, Pawar AP, et al. Fisetin-loaded nanocochleates: formulation, characterisation, in vitro anticancer testing, bioavailability and biodistribution study. Expert Opin. Drug Deliv. 2014;11:17–29.
   PubMed Web of Science ®Google Scholar
• Nishioka Y, Yoshino H. Lymphatic targeting with nanoparticulate system. Adv Drug Deliv Rev. 2001;47:55–64.
   PubMed Web of Science ®Google Scholar
• Soma D, Kitayama J, Ishigami H, et al. Different tissue distribution of paclitaxel with intravenous and intraperitoneal administration. J Surg Res. 2009;155:142–146.
   PubMed Web of Science ®Google Scholar